The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
Clicks: 122
ID: 271373
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
122 views
13 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #657 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Surveillance for candidemia across 9 US states during 2017 revealed that 10.7% of cases involved recent injection drug use (IDU)—unexpectedly high for what is p
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (23 words).
Try re-searching for a better abstract.
| Reference Key |
y2020clinicalthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhang, Alexia Y;Shrum, Sarah;Williams, Sabrina;Petnic, Sarah;Nadle, Joelle;Johnston, Helen;Barter, Devra;Vonbank, Brittany;Bonner, Lindsay;Hollick, Rosemary;Marceaux, Kaytlynn;Harrison, Lee;Schaffner, William;Tesini, Brenda L;Farley, Monica M;Pierce, Rebecca A;Phipps, Erin;Mody, Rajal K;Chiller, Tom M;Jackson, Brendan R;Vallabhaneni, Snigdha; |
| Journal | clinical infectious diseases |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.